Evidence map›Paper›PMID 41071499›Full record

ArticleAIDS and behavior2026

Trends in Alcohol Use Before and During the COVID-19 Pandemic Among Women Living With and Without HIV in the United States (2017-2022).

Hannah R Tierney, Yifei Ma, Fan Xia, Aruna Chandran, Mirjam-Colette Kempf, Lauren F Collins, Jack DeHovitz, Ralph J DiClemente, Michelle Floris-Moore, Audrey L French and 6 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hannah R TierneyDepartment of Medicine, University of California, San Francisco, 505 Parnassus Ave # M1480, San Francisco, CA, 94143-0454, USA. hannah.tierney@ucsf.edu.ORCID http://orcid.org/0000-0001-8316-3451
Yifei MaDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Fan XiaDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Aruna ChandranDepartment of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA.
Mirjam-Colette KempfSchools of Nursing, Medicine and Public Health Birmingham, University of Alabama at Birmingham, Alabama, USA.
Lauren F CollinsDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Jack DeHovitzDepartment of Medicine, State University of New York-Downstate Medical Center, Brooklyn, NY, USA.
Ralph J DiClementeDepartment of Social and Behavioral Sciences, NYU School of Global Public Health, New York, NY, USA.
Michelle Floris-MooreDivision of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Audrey L FrenchDepartment of Medicine, Division of Infectious Diseases, Stroger Hospital of Cook County, Chicago, IL, USA.
Deborah L JonesDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Anjali SharmaDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, USA.
Amanda B SpenceDivision of Infectious Diseases, Georgetown University Medical Center, District of Columbia, Washington, USA.
Judith A HahnDivision of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, USA.
Jennifer C PriceDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Phyllis C TienDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
SF Bay Area MACS/WIHS Combined Cohort StudyU01HL146242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bradley E Aouizerat, Jennifer Cohen Price · 2019 to 2026
$36.3M
Sex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosisU01HL146193 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Stephen J Gange, Elizabeth Topper · 2019 to 2026
$35.8M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8M
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center - Admin Supplement: Vision and dual sensory loss in HIV-infected older adultsU01HL146201 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TODD T BROWN, Joseph B. Margolick · 2019 to 2026
$33.7M
Sex differences in the role of multi-omics in HIV-associated carotid artery atherosclerosisU01HL146204 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI David B. Hanna, Anjali Sharma · 2019 to 2026
$33.2M
University of Pittsburgh MWCCS Clinical Research SiteU01HL146208 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bernard Jonas C Macatangay, CHARLES R RINALDO · 2019 to 2026
$32.2M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30-AI-027767Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30-AI-050409Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30-AI-050410Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30-AI-073961National Institute of Mental Health and Neurosciences P30-MH-116867NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1-TR000004NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1-TR001881NCATS NIH HHS UL1 TR003098NCATS NIH HHS UL1-TR003098NHLBI NIH HHS U01 HL146192NHLBI NIH HHS U01-HL146192NHLBI NIH HHS U01 HL146193NHLBI NIH HHS U01-HL146193NHLBI NIH HHS U01 HL146194NHLBI NIH HHS U01-HL146194NHLBI NIH HHS U01 HL146201NHLBI NIH HHS U01-HL146201NHLBI NIH HHS U01 HL146202NHLBI NIH HHS U01-HL146202NHLBI NIH HHS U01 HL146203NHLBI NIH HHS U01-HL146203NHLBI NIH HHS U01 HL146204NHLBI NIH HHS U01-HL146204NHLBI NIH HHS U01 HL146205NHLBI NIH HHS U01-HL146205NHLBI NIH HHS U01 HL146208NHLBI NIH HHS U01-HL146208NHLBI NIH HHS U01 HL146240NHLBI NIH HHS U01-HL146240NHLBI NIH HHS U01 HL146241NHLBI NIH HHS U01-HL146241NHLBI NIH HHS U01 HL146242NHLBI NIH HHS U01-HL146242NHLBI NIH HHS U01 HL146245NHLBI NIH HHS U01-HL146245NHLBI NIH HHS U01 HL146333NHLBI NIH HHS U01-HL146333NIAAA NIH HHS K24 AA022586NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIA NIH HHS K23 AG084415NIMH NIH HHS P30 MH116867
6 · The paper itself

Abstract

Data on alcohol use trends in women living with HIV (WLWH) are lacking. We examine data collected before and across the COVID-19 pandemic (2014-2022) in WLWH and socio-demographically similar women living without HIV (WLWOH)(n = 1564; 67% WLWH) who self-reported alcohol use to establish and compare trends. Women were categorized into baseline groups based on use pattern from 10/2014 to 09/2017: abstinence (no alcohol at any visit), non-heavy drinking (0 heavy drinking visits), some heavy drinking (1-4 visits), and persistent heavy drinking (5-6 visits) with heavy drinking defined as > 7 drinks/week or > 3 drinks/day. A linear mixed model (LMM) was used to assess for changes in average number of drinks/week (ADW) by time segment: pre-pandemic (10/2017-09/2019), early pandemic (08/2020-05/2021), and late pandemic (06/2021-09/2022). Time, baseline group, and HIV status were included as interactions. In the LMM, WLWH with persistent heavy drinking histories had lower ADW compared to WLWOH. There were no significant differences in ADW in the other groups by HIV status and no significant interactions between HIV status and the time segments. The largest change in ADW occurred among the persistent heavy drinking group, with decreases at pandemic onset followed by increases into 2021. Overall, WLWH reported less alcohol use than WLWOH, but changes in alcohol use trends from 10/2017 to 09/2022 were similar regardless of HIV status. This suggests that the pandemic did not uniquely impact alcohol use among WLWH, rather socio-economically disadvantaged women generally. These findings support the need for greater research in the role of socioeconomic disruption on alcohol use among women.

Indexed as

Alcohol DrinkingCOVID-19HIV InfectionsAdultFemaleHumansMiddle AgedPandemicsSARS-CoV-2United StatesAlcohol consumptionAlcohol useCOVID-19 pandemicHIVWomen

Identifiers

PMID41071499
PMCPMC12795451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.